Programme

Wednesday, April 26th, 2023

1:15 – 1:30 pm

Welcome and introduction

1:30 – 2:00 pm

Plenary 1 : GIP and Cushing, 30 years later
Prof. André Lacroix (Montreal)

2:00 – 3:30 pm

Session 1 : Adrenals covering Pheo/PGL
Supervisor: Ana Hoff – Anne-Paule Gimenez-Roqueplo – Anne Barlier

2:00 - 2:10 pmUnmet needs
Prof. Anne-Paule Gimenez-Roqueplo (Paris)
2:10 - 2:30 pmAberrant receptor expression in pheochromocytoma
Prof. Hervé Lefebvre (Rouen)
2:30 - 2:50 pmImmunogenomics in metastatic pheochromocytoma and paraganglioma
Dr. Bruna Calsina (Spain)
2:50 - 3:10 pmTumor microenvironment in PPGL
Prof. Richard Tothill (Australia)
3:10 - 3:30 pmDiscussion

3:30 – 3:45 pm

Break

3:45 – 5:15 pm

Session 2 : MTC and MEN2
Supervisor: Steven Waguespack – Julien Hadoux - Frédéric Sebag

3:45 - 3:55 pmUnmet needs
Dr. Julien Hadoux (France)
3:55 - 4:15 pmEarly thyroidectomy in MEN2
Prof. Steven Waguespack (USA)
4:15 - 4:35 pmWhat dictates the natural history of MTC in MEN2?
Prof. Rossella Elisei (Italy)
4:35 - 4:55 pmManagement of advanced RET+ MTC
Prof. Mimi Hu (USA)
4:55 - 5:15 pmDiscussion

Thursday, April 27th, 2023

8:30 – 9:00 am

Plenary 2 : USP8, 8 years later
Prof. Marily Theodoropoulou (Munich, Germany)


9:00 – 10:30 am

Session 3 : Pituitary
Supervisor: Thierry Brue - Albert Beckers

9:00 - 9:10 amUnmet needs
Prof. Frédéric Castinetti (Marseille)
9:10 - 9:30 amThe mechanisms of resistance to glucocorticoids in Cushing’s disease
Prof. Jacques Drouin (Montreal, Canada)
9:30 - 9:50 amMicroenvironment in pituitary tumors
Dr. Philippe Bertolino (Lyon, France)
9:50 - 10:10 amPituitary stem cells and tumorigenesis
Dr. Cynthia Andoniadou (London, UK)
10:10 - 10:30 amDiscussion

10:30 – 10:45 am

Break


10:45 – 12:15 pm

Session 4 : NETs
Supervisor: Gerlof Valk - David Taieb

10:45 - 10:55 amUnmet needs
Prof. Gerlof Valk (Pays-Bas)
10:55 - 11:15 amImage guided NET therapy (radiologic and nuclear therapies)
Dr. Arthur Braat (Utrecht, The Netherlands)
11:15 - 11:35 amOrganoids in NEN
Dr. Talya Daton (Barcelona, Spain)
11:35 - 11:55 amMedical treatment of metastasized PanNET
Pr. Thomas Walter (Lyon, France)
11:55 - 12:15 pmDiscussion

12:15 - 1:00 pm

Oral, small molecule G-Protein Coupled Receptor agonists & antagonist in Endocrinology - Dr. Peter Trainer (UK)


1:00 – 1:45 pm

Lunch



The FIRMO Parathyroid medal
Prof. Maria Luisa Brandi


2:00 – 3:30 pm

Session 5 : Parathyroid diseases
Supervisor: Prof. Maria Luisa Brandi - Samira Sadowski - Thomas Cuny

2:00 - 2:10 pmUnmet needs
Prof. Maria Luisa Brandi (Italy)
2:10 - 2:30 pmPrimary HPTH in the pediatric population
Dr. Omair Shariq (USA)
2:30 - 2:50 pmIs targeting the MEN1 gene close?
Prof. Sunita Agarwal (USA)
2:50 - 3:10 pmSurgical path of MEN1 HPTH during lifetime
Prof. Nancy Perrier (USA)
3:10 - 3:30 pmDiscussion

3:30 – 4:00 pm

Break


4:00 – 5:00 pm

Session 6: Unmet needs and patients’ expectations
Supervisor: Mark Lewis

4:00 - 4:15 pmQuality of life and coping in MEN2
Dr. Ana Hoff
4:15 - 4:30 pmQuality of life and coping in Cushing’s disease
Prof. Frederic Castinetti (France)
4:30 - 4:50 pmThe patients’ perspectives seen by patients’ associations
Jo Grey (UK)
4:50 - 5:00 pmDiscussion

Friday, April 28th, 2023

8:30 – 10:00 am

Session 7: Genetics and Pediatrics
Supervisor: Steven Waguespack - Constantine Stratakis – Rachel Reynaud

8:30 - 8:40 amUnmet needs
Prof. Steven Waguespack (USA)
8:40 - 9:00 amAn Update in the genetics of pituitary tumors
Prof. Marta Korbonits (UK)
9:00 - 9:20 amAn Update on the DICER1 syndrome
Prof. William Foulkes (Montreal, Canada)
9:20 - 9:40 amSuccesses and challenges in screening children for hereditary tumors
Prof. Anita Villani (Toronto, Canada)
9:40 - 10:00 amDiscussion

10:00 - 10:15 am

Break

10:15 – 11:30 am

Session 8: MEN1 Update and guidelines
Supervisor: R. Thakker

11:30 – 12:30 pm

« New tools and treatments in endocrine diseases » endorsed by the French Endocrine Society

11:30 - 11:50 am« Immunotherapy in pituitary carcinoma »                            Prof. Gerald Raverot
11:50 - 12:10 am«Therapeutic advances in metastatic PPGL »                        Dr. Magalie Haissaguerre 
12:10 - 12:30 pm« Merits of 1H-MR spectroscopy in neuroendocrine tumors »                                                                                          Prof. Charlotte Lussey-Lepoutre


12:30 – 12:50 pm

Best abstract (3x10 minutes oral communications)

1:0 – 1:10 pm

Conclusions - R. Thakker and F. Castinetti